Acarbose Tablets 50mg – Experimental Use Only

Acarbose Tablets 50mg – Experimental Use Only

$1.00

Acarbose Tablets 50mg, intended for scientific research and laboratory studies on carbohydrate metabolism, manufactured by Beijing Jingfeng Pharmaceutical Group Co., Ltd. Not for human use.?For wholesale prices, other specifications and uses, please consult our staff?

EMI starting from $0.00/month - View Plans
Compare
分类:

描述

Acarbose Tablets are alpha-glucosidase inhibitors commonly used in experimental models studying postprandial glucose control, carbohydrate digestion, and type 2 diabetes mellitus (T2DM). These tablets delay glucose absorption from the intestine by inhibiting enzymes that break down complex carbohydrates, making them essential in metabolic and pharmacological research.

Manufactured by Beijing Jingfeng Pharmaceutical Group Co., Ltd., this formulation is approved under NMPA approval number H20233870 and offered in a 50mg strength.

?? For laboratory and research use only. Not for clinical, diagnostic, or therapeutic purposes.


Product Parameters

Attribute Details
Product Name Acarbose Tablets
Chinese Name ?????
CAS Number 56180-94-0
Molecular Formula C25H43NO18
Strength 50mg
Dosage Form Tablets
Specification 50mg × 15 tablets × 2 blisters per box
Approval Number H20233870
Product Code 86900062000485
Manufacturer Beijing Jingfeng Pharmaceutical Group Co., Ltd.
Packaging Boxed tablets
Use Limitation For experimental/laboratory use only
Storage Store in a cool, dry place below 25°C

Mechanism & Research Applications

Acarbose is a reversible inhibitor of intestinal alpha-glucosidases, such as maltase and sucrase. It reduces the digestion of complex carbohydrates into glucose, resulting in delayed and reduced postprandial blood glucose levels.

Research uses include:

  • Experimental models of type 2 diabetes mellitus (T2DM)

  • Investigations into carbohydrate absorption and metabolism

  • Studies on alpha-glucosidase enzyme activity

  • Combination therapy research with insulin or oral antidiabetics


Observed Effects in Research

In lab-based studies, Acarbose has shown:

  • Reduced post-meal glucose spikes

  • Altered gut microbiota profile

  • Delayed glucose absorption in intestinal tissue

  • Synergistic effects when used with metformin or insulin analogs

  • Improvement in glycemic control markers in T2DM models


Safety & Handling

  • Use: Laboratory/Research use only

  • PPE: Wear lab coat, gloves, and eye protection

  • Storage: Store below 25°C in original packaging

  • Disposal: Dispose of in accordance with laboratory chemical waste protocols


Research Use Disclaimer

This product is strictly for laboratory research purposes only. It is not for use in humans or animals. Misuse of this product may violate local or international regulations. Use only in approved research settings.

其他信息

重量 1 公斤
尺寸 26 × 23 × 26 厘米

评价

目前还没有评价

成为第一个“Acarbose Tablets 50mg – Experimental Use Only” 的评价者

您的邮箱地址不会被公开。 必填项已用 * 标注

Q1: What is the primary use of Acarbose in lab research?

Acarbose is commonly used in type 2 diabetes research to study its effects on carbohydrate digestion and postprandial glucose regulation.

Q2: Is this product approved for human therapeutic use?

No. This Acarbose formulation is for laboratory research use only. It is not intended for human or animal consumption.

Q3: What are the active ingredients in these tablets?

Each tablet contains 50mg of Acarbose as the active pharmaceutical ingredient.

Q4: Do you offer COA and SDS for this product?

Yes. COA (Certificate of Analysis) and SDS (Safety Data Sheet) are available upon request with your order.

Q5: Why is Acarbose significant in diabetes research?

Its ability to delay carbohydrate absorption and reduce postprandial glucose makes Acarbose highly valuable in evaluating non-insulin-dependent mechanisms in glucose regulation models.


EMI Options

Select at least 2 products
to compare